BRCA2 and prostate carcinoma: Since the castration-resistant prostate cancer cells assayed in this study have decreased BRCA2 levels compared to the normal PNT1A cells, it is possible that reduced repair of 6-TG-induced DSBs by HR contributes to activation of apoptosis in cancer cells.